2024-03-05 14:23:17 ET
Amgen Inc. (AMGN)
TD Cowen 44th Annual Health Care Conference
March 05, 2024 09:10 AM ET
Company Participants
Peter Griffith - Chief Financial Officer
Paul Burton - Chief Medical Officer
Conference Call Participants
Yaron Werber - TD Cowen
Presentation
Yaron Werber
All right. Well, welcome once again to the 44th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the fireside chat next with Amgen, first fireside chat for the day, so have very high expectations.
With us today is Peter Griffith, the Chief Financial Officer; Paul Burton, Chief Medical Officer; and Justin Claeys, VP of IR; Casey in the audience as well. So, gentlemen, thanks for joining us. We appreciate it.
Peter let me turn it over to your opening remarks and then we'll dive into Q&A.
Peter Griffith
Thank you, Yaron. Thank you, TD Cowen. It's great to be here at the 44th Conference. Listen, we're here today on behalf of 27,000 plus colleagues at Amgen. Our mission is to serve patients. And this is an exciting time for Amgen. We see significant long-term growth opportunities across all four of our therapeutic pillars. Numerous catalysts this year including two PDUFA dates in June. I'll talk about those in a moment. Five Phase 3 and three Phase 2 data readouts....
Read the full article on Seeking Alpha
For further details see:
Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)